approval · primary record
DAPAGLIFLOZIN
FDA · NDA · 2026-06-03
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-06-03 |
| Brand | QTERN |
| Sponsor | ASTRAZENECA AB |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:24.901Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DAPAGLIFLOZIN:2026-06-03
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.